Mark Mullikin | Senior Director of Finance and Investor Relations |
Cindy Collins | Chief Executive Officer |
Charlie Albright | Chief Scientific Officer |
Vic Myer | Chief Technology Officer |
Andrew Hack | Chief Financial Officer |
Hannah Latimer | Morgan Stanley |
Matthew Thomas | J.P. Morgan |
Whitney Ijem | Guggenheim |
Phil Nadeau | Cowen & Company |
Amanda Murphy | BTIG |
Peter Lawson | SunTrust Robinson |
Steve Seedhouse | Raymond James |
Good afternoon, and welcome to Editas Medicine’s Fourth Quarter and Full-Year 2018 Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the company’s request. I would now like to turn the call over to Mark Mullikin, Senior Director of Finance and Investor Relations at Editas Medicine.